Improving Therapeutic Learning for PTSD

Summary

Improving Therapeutic Learning for PTSD is a clinical trial^[1].

Key Facts

• Improving Therapeutic Learning for PTSD is in the country of United States^[2].
• Improving Therapeutic Learning for PTSD's instance of is recorded as clinical trial^[3].
• Improving Therapeutic Learning for PTSD's start time is recorded as +2020-11-30T00:00:00Z^[4].
• Improving Therapeutic Learning for PTSD's end time is recorded as +2023-12-31T00:00:00Z^[5].
• Improving Therapeutic Learning for PTSD's contributor to the creative work or subject is recorded as National Institute of Mental Health^[6].
• Improving Therapeutic Learning for PTSD's sponsor is recorded as University of Wisconsin–Madison^[7].
• Improving Therapeutic Learning for PTSD's number of participants is recorded as {'unit': '1', 'amount': '+120'}^[8].
• Improving Therapeutic Learning for PTSD's title is recorded as Improving Therapeutic Learning for PTSD^[9].
• Improving Therapeutic Learning for PTSD's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+21'}^[10].
• Improving Therapeutic Learning for PTSD's ClinicalTrials.gov ID is recorded as NCT04558112^[11].
• Improving Therapeutic Learning for PTSD's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+50'}^[12].
• Improving Therapeutic Learning for PTSD's research intervention is recorded as levodopa^[13].
• Improving Therapeutic Learning for PTSD's clinical trial phase is recorded as phase II clinical trial^[14].
• Improving Therapeutic Learning for PTSD's research site is recorded as University of Wisconsin–Madison^[15].
• Improving Therapeutic Learning for PTSD's research subject recruitment status is recorded as not yet recruiting^[16].
• Improving Therapeutic Learning for PTSD's study type is recorded as interventional study^[17].